Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1987 2
1989 1
1991 1
1992 2
1993 1
1994 1
1996 3
1997 1
1998 2
1999 2
2001 3
2002 2
2003 2
2004 7
2005 6
2006 8
2007 7
2008 9
2009 9
2010 12
2011 17
2012 14
2013 19
2014 19
2015 19
2016 16
2017 13
2018 20
2019 20
2020 21
2021 21
2022 18
2023 11
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of adult Graves' disease.
Corvilain B, Hamy A, Brunaud L, Borson-Chazot F, Orgiazzi J, Bensalem Hachmi L, Semrouni M, Rodien P, Lussey-Lepoutre C. Corvilain B, et al. Among authors: borson chazot f. Ann Endocrinol (Paris). 2018 Dec;79(6):618-635. doi: 10.1016/j.ando.2018.08.003. Epub 2018 Aug 16. Ann Endocrinol (Paris). 2018. PMID: 30193753 Review.
Management of clinically non-functioning pituitary adenoma.
Chanson P, Raverot G, Castinetti F, Cortet-Rudelli C, Galland F, Salenave S; French Endocrinology Society non-functioning pituitary adenoma work-group. Chanson P, et al. Ann Endocrinol (Paris). 2015 Jul;76(3):239-47. doi: 10.1016/j.ando.2015.04.002. Epub 2015 Jun 10. Ann Endocrinol (Paris). 2015. PMID: 26072284 Free article. Review.
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome.
Tabarin A, Assié G, Barat P, Bonnet F, Bonneville JF, Borson-Chazot F, Bouligand J, Boulin A, Brue T, Caron P, Castinetti F, Chabre O, Chanson P, Corcuff JB, Cortet C, Coutant R, Dohan A, Drui D, Espiard S, Gaye D, Grunenwald S, Guignat L, Hindie E, Illouz F, Kamenicky P, Lefebvre H, Linglart A, Martinerie L, North MO, Raffin-Samson ML, Raingeard I, Raverot G, Raverot V, Reznik Y, Taieb D, Vezzosi D, Young J, Bertherat J. Tabarin A, et al. Among authors: borson chazot f. Ann Endocrinol (Paris). 2022 Apr;83(2):119-141. doi: 10.1016/j.ando.2022.02.001. Epub 2022 Feb 19. Ann Endocrinol (Paris). 2022. PMID: 35192845 Review.
Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP).
Brue T, Rahabi H, Barry A, Barlier A, Bertherat J, Borson-Chazot F, Castinetti F, Cazabat L, Chabre O, Chevalier N, Christin-Maitre S, Cortet C, Drui D, Kamenicky P, Lançon C, Lioté F, Pellegrini I, Reynaud R, Salenave S, Tauveron I, Touraine P, Vantyghem MC, Vergès B, Vezzosi D, Villa C, Raverot G, Coutant R, Chanson P, Albarel F. Brue T, et al. Among authors: borson chazot f. Ann Endocrinol (Paris). 2023 Dec;84(6):697-710. doi: 10.1016/j.ando.2023.08.003. Epub 2023 Aug 12. Ann Endocrinol (Paris). 2023. PMID: 37579837 Review.
La prise en charge des cancers médullaires de la thyroïde en 2024.
Lasolle H, Borson-Chazot F, Gauduchon T, Haissaguerre M, Illouz F, Lifante JC, Lussey-Lepoutre C, Prunier D, Sajous C, Varnier R, Hadoux J. Lasolle H, et al. Among authors: borson chazot f. Bull Cancer. 2024 Oct;111(10S1):10S53-10S63. doi: 10.1016/S0007-4551(24)00408-9. Bull Cancer. 2024. PMID: 39505437 Review. French.
[Checkpoint inhibitors-induced hypophysitis].
du Payrat JA, Cugnet-Anceau C, Maillet D, Levy M, Raverot G, Disse E, Borson-Chazot F. du Payrat JA, et al. Among authors: borson chazot f. Bull Cancer. 2020 Apr;107(4):490-498. doi: 10.1016/j.bulcan.2020.01.012. Epub 2020 Mar 19. Bull Cancer. 2020. PMID: 32200950 Review. French.
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, Nölting S, de la Fouchardière C, Kienitz T, Deutschbein T, Zovato S, Amar L, Haissaguerre M, Timmers H, Niccoli P, Faggiano A, Angokai M, Lamartina L, Luca F, Cosentini D, Hahner S, Beuschlein F, Attard M, Texier M, Fassnacht M; ENDOCAN-COMETE; ENSAT Networks. Baudin E, et al. Lancet. 2024 Mar 16;403(10431):1061-1070. doi: 10.1016/S0140-6736(23)02554-0. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402886 Clinical Trial.
284 results